Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 1239-1241, 2008; 10.1373/clinchem.2007.101428
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van der Watt, G.
Right arrow Articles by Berman, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van der Watt, G.
Right arrow Articles by Berman, P.
Related Collections
Right arrow Clinical Case Studies
(Clinical Chemistry. 2008;54:1239-1241.)
© 2008 American Association for Clinical Chemistry, Inc.

Clinical Case Studies

Euthyroid Patient with Elevated Serum Free Thyroxine

George van der Watt1,a, David Haarburger1 and Peter Berman1

1 Division of Chemical Pathology, National Health Laboratory Service, Groote Schuur and Red Cross Children’s Hospitals, University of Cape Town, Observatory, South Africa.

aAddress correspondence to this author at: Division of Chemical Pathology, National Health Laboratory Service, Groote Schuur and Red Cross Children’s Hospitals, University of Cape Town, Observatory, South Africa, 7925. Fax +27216585225; e-mail george.vanderwatt@chempath.uct.ac.za

The first 20% of the full text of this article appears below.


CASE

A 32-year-old female patient presented complaining of increased flushing, perspiration and heat intolerance of 3 months’ duration. Medical history included idiopathic thrombocytopenic purpura of 4 years’ duration, which had been treated by splenectomy after failed immunosuppression with prednisone and azathioprine and was currently in remission. On examination, she was found to be clinically euthyroid without a goiter. She had also developed a diffuse erythematous papular rash on the face and back, with bullous lesions on the chest. Immunofluorescent antibody studies performed on a punch biopsy of skin were positive for several autoantibodies, leading to a diagnosis of subacute cutaneous lupus erythematosus. This diagnosis was further characterized by positive titers of nuclear and double-stranded DNA autoantibodies in the serum. Thyroid function testing on an Advia Centaur® Immunoassay System (Siemens Medical Solutions Diagnostics) revealed an increased concentration of serum free thyroxine (FT4)1 of 90.1 pmol/L (6.97 ng/dL) (reference range 11.5–22.7 pmol/L), a nonsuppressed thyroid-stimulating hormone (TSH) concentration of 1.8 mIU/L (1.8 µIU/mL) (reference range 0.35–5.5 mIU/L), and normal free triiodothyronine (FT3) concentration of 4.2 pmol/L (0.33 ng/dL) (reference range 3.5–6.5 pmol/L). Repeat investigation 1 and 2 months later revealed a progressive increase in FT4 to 125.3 pmol/L (9.7 ng/dL) and ≥155 pmol/L (≥12.0 ng/dL), respectively. TSH and FT3 remained within reference intervals, as did total T4 by RIA, at 155 nmol/L (12 µg/dL) (reference range 58–161 nmol/L). Furthermore, she tested positive for antithyroperoxidase antibodies at 110 IU/L (reference range <37 IU/L) and antithyroglobulin antibodies at 149 IU/L (reference range <98.1 IU/L). An investigation of her disconcordant thyroid function tests was initiated.


DISCUSSION

Increased serum FT4 concentrations, with a nonsuppressed TSH, are most often seen with . . . [Full Text of this Article]


FURTHER INVESTIGATIONS

peg precipitates radiolabeled t4
peg precipitation eliminates interference

POINTS TO REMEMBER






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.